Interactive Patient Case: Multidisciplinary Management of SMA
Healthcare professionals working through this patient-case module will learn about advances in the multidisciplinary management of patients with spinal muscular atrophy (SMA). The interactive patient case discusses current best practices in diagnosis, pulmonary and orthopedic care, rehabilitation, nutritional care, and medication. After completing the module, learners will be able to explain the importance of genetic testing, describe best practices for the management of various complications of SMA, apply standardized assessment tools, and understand how medication can be implemented in the care plan for their patients with SMA.
This activity has been designed to meet the educational needs of neurologists, pediatricians, pulmonologists, physical therapists, and other HCPs, such as orthopedists, who are involved in the diagnosis, treatment, or management of patients with SMA.
Upon completion of this activity, participants will be able to:
- Classify SMA type based on neurological examination and molecular profiling
- Apply the best procedure for early diagnosis and treatment initiation
- Recognize the importance of a multidisciplinary approach to SMA management
- Outline best practices for the management of various complications of all SMA types
- Select and apply standardized assessment tools for clinical changes
- Implement early interventions to reduce complications of SMA
Julie A. Parsons, MD
Disclosure of Conflicts of Interest
It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose any real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
|Faculty||Relationship Identified With:|
|Julie A. Parsons, MD|
Consultant/Advisor: AveXis, Inc., Biogen, PTC Therapeutics, Sarepta TherapeuticsGrant/Research Support: AveXis, Inc., Biogen, Cytokinetics, PTC Therapeutics, Sarepta Therapeutics
Non-faculty: Marijke Verhaaf; Cordelia Nagle; Elena Knoche, PhD; Sandy Breslow; Alison Kemp; and Bernard M. Abrams, MD hereby state that neither they nor their spouse/life partner have had any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This activity has been supported by an independent educational grant from Biogen.
Jointly provided by the Elsevier Office of Continuing Medical Education, Dannemiller, and Ology Medical Education.
CME Credit (Physicians)
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and Ology Medical Education. The Elsevier Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE CREDITS (NURSING)
In support of improving patient care, this activity has been planned and implemented by Dannemiller and Elsevier Office of Continuing Medical Education. Dannemiller is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Dannemiller designates this educational activity for 0.5 contact hours.
CME INQUIRIES/SPECIAL NEEDS
For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.
Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Dannemiller, Ology Medical Education, and Biogen do not recommend the use of any agent outside of the labeled indications.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
- 0.50 AMA PRA Category 1 Credit(s)™
- 0.50 Nursing Contact Hours
- 0.50 Non-physician